Daily Medical Update

Multiple sclerosis

Saturday, September 12, 2026

🔬 Practice-Changing Findings
Evidence from RCTs and meta-analyses published in the last 12 months.

1. ACR Appropriateness Criteria® Demyelinating Diseases.

Journal of the American College of Radiology : JACR (2026) - Practice Guideline

Key Findings

  • The updated imaging guidance reports 94% diagnostic accuracy at 3T MRI when the 2024 McDonald criteria are integrated with advanced MRI features.
  • Central vein sign, paramagnetic rim lesions, and gadolinium-enhancement patterns improve distinction between active inflammatory lesions, chronic plaques, and alternative demyelinating disorders.

📋 Practice Implication: When evaluating suspected or established MS, clinicians should coordinate MRI protocols with radiology so lesion morphology, activity, and key differential-diagnosis features are captured consistently.

2. Comparative efficacy of non- pharmacological interventions on sleep quality in patients with multiple sclerosis: a systematic review and network meta-analysis.

PeerJ (2026) - Network Meta-Analysis

Key Findings

  • Across 35 studies involving 2,804 participants, occupational-therapy sleep interventions ranked highest for subjective sleep quality (SUCRA 94.2%), followed by mindfulness (85.9%) and sleep-hygiene education (78.6%).
  • Effleurage massage ranked highest for reducing insomnia severity (SUCRA 91.9%), with cognitive-behavioral therapy next (80.1%).

📋 Practice Implication: Sleep care in MS can be tailored toward occupational-therapy-based programs or CBT-oriented approaches, with the choice guided by whether the dominant problem is poor sleep quality or insomnia severity.

3. Is serum neurofilament light chain accurate enough to guide multiple sclerosis care? Diagnostic performance and optimal cutoff in a systematic review and meta-analysis.

Multiple sclerosis and related disorders (2026) - Systematic Review

Key Findings

  • In 28 studies comprising 11,213 patients, pooled diagnostic performance for MS disease activity was modest, with AUC values of 0.61-0.71 (61%-71%).
  • A 10 pg/mL cutoff for clinical relapse produced sensitivity of 0.69, specificity of 0.65, and AUC of 0.72; 50% of studies were judged at high risk of bias.

📋 Practice Implication: sNfL should not be used as a standalone trigger for treatment decisions; interpret it alongside symptoms, examination, MRI findings, assay context, and longitudinal trends.

4. Predictors of Multiple Sclerosis After Clinically Isolated Syndrome: A Systematic Review and Meta-Analysis.

European journal of neurology (2026) - Systematic Review

Key Findings

  • Among 72 studies and 9,915 adults with CIS, younger age and multifocal presentation were associated with subsequent MS diagnosis (odds ratios 1.60 and 1.55, respectively).
  • Higher T2 lesion burden and periventricular, corpus callosum, infratentorial, spinal-cord, and gadolinium-enhancing lesions, plus CSF oligoclonal bands, were also associated with conversion (odds ratios 1.40-14.89).

📋 Practice Implication: Risk assessment after CIS should integrate clinical presentation, lesion distribution and burden, and CSF inflammatory markers to identify patients needing closer surveillance and individualized early-treatment discussions.

5. Prognostic value of neurofilament light chain protein and glial fibrillary acidic protein in multiple sclerosis subtypes and disease activity patterns: a systematic review and meta-analysis.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2026) - Systematic Review

Key Findings

  • Across 13 studies involving 4,016 individuals, each unit increase in NfL was associated with a 4% increase in adverse-event risk; levels above a threshold were associated with 2.61-fold higher risk.
  • NfL had stronger predictive performance in relapsing-remitting MS than in mixed disease (RR 3.82 vs 1.03) and was associated with neurodegenerative EDSS worsening, whereas GFAP showed no significant overall prognostic value.

📋 Practice Implication: NfL may support subtype-aware prognosis and monitoring for silent neurodegenerative progression, but GFAP should not currently be treated as an independent prognostic marker.

💡 Summary

The selected high-significance studies emphasize updated MRI criteria, modifiable symptom management, and risk stratification after clinically isolated syndrome. Biomarker evidence is complementary rather than interchangeable: serum neurofilament light chain shows subtype- and activity-dependent prognostic value, while its standalone diagnostic accuracy remains limited.

Generated from 120 PubMed abstracts · RCTs and Meta-analyses only

Next topic: Catheter-related infections

Unsubscribe  ·  Subscribe